Generics Claris Lifesciences, a leading Indian injectable generic pharmaceuticals maker, has said that, following approval by the US Food and Drug Administration of the corrective actions taken at its plant in Ahmedabad, the company can now manufacture and sell its products in the USA. It can also receive Abbreviated New Drug Application (ANDA) approvals, the company added. 27 August 2012